BKV (NYSE:BKV) Price Target Cut to $31.00 by Analysts at Truist Financial

Key Points

• Truist Financial lowered its BKV price target to $31 from $34 but kept a Buy rating; the new target implies 77.35% upside from the stock’s current price.
• Analyst sentiment is broadly positive: BKV has a consensus Moderate Buy rating and an average price target of $33.33. The stock opened at $17.48.
• BKV’s latest quarter beat revenue expectations with $478.37 million, but earnings per share of $0.36 narrowly missed the $0.38 consensus estimate.

BKV (NYSE:BKV - Get Free Report) had its target price reduced by analysts at Truist Financial from $34.00 to $31.00 in a research report issued to clients and investors on Monday, Benzinga reports. The firm currently has a "buy" rating on the stock. Truist Financial's price objective would suggest a potential upside of 77.35% from the company's current price.

BKV has been the subject of a number of other research reports. Evercore raised shares of BKV to a "strong-buy" rating in a report on Friday, September 18th. Zacks Research cut BKV from a "strong-buy" rating to a "hold" rating in a research note on Wednesday, November 4th. Weiss Ratings cut BKV from a "hold (c+)" rating to a "hold (c)" rating in a research note on Friday, October 23rd. Susquehanna decreased their price objective on BKV from $37.00 to $35.00 and set a "positive" rating on the stock in a research report on Tuesday, July 21st. Finally, Wall Street Zen downgraded BKV from a "sell" rating to a "strong sell" rating in a research report on Saturday, October 17th. One analyst has rated the stock with a Strong Buy rating, eight have given a Buy rating and two have assigned a Hold rating to the company. According to MarketBeat.com, the company currently has a consensus rating of "Moderate Buy" and an average price target of $33.33.

BKV Price Performance

BKV stock opened at $17.48 on Monday. The company has a market cap of $1.91 billion, a price-to-earnings ratio of 8.28 and a beta of 1.13. The firm's fifty day moving average is $22.61 and its 200 day moving average is $26.34. The company has a quick ratio of 3.18, a current ratio of 3.25 and a debt-to-equity ratio of 0.83. BKV has a 52-week low of $17.47 and a 52-week high of $32.81.

BKV (NYSE:BKV - Get Free Report) last issued its quarterly earnings data on Thursday, November 5th. The company reported $0.36 EPS for the quarter, missing analysts' consensus estimates of $0.38 by ($0.02). BKV had a return on equity of 6.12% and a net margin of 12.87%. The business had revenue of $478.37 million during the quarter, compared to analysts' expectations of $395.18 million. Sell-side analysts forecast that BKV will post 1.47 EPS for the current fiscal year.

Insider Buying and Selling at BKV

In other BKV news, SVP Javier Hinojosa sold 12,377 shares of the business's stock in a transaction that occurred on Friday, August 21st. The stock was sold at an average price of $25.73, for a total transaction of $318,460.21. Following the completion of the transaction, the senior vice president owned 84,276 shares in the company, valued at $2,168,421.48. The trade was a 12.81% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CFO David Tameron sold 4,321 shares of the company's stock in a transaction that occurred on Thursday, August 20th. The shares were sold at an average price of $26.56, for a total value of $114,765.76. Following the transaction, the chief financial officer directly owned 58,524 shares in the company, valued at approximately $1,554,397.44. This represents a 6.88% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold 40,578 shares of company stock worth $1,005,136 over the last 90 days. Company insiders own 2.51% of the company's stock.

Hedge Funds Weigh In On BKV

Several hedge funds have recently bought and sold shares of BKV. BlackRock Inc. purchased a new stake in BKV in the 2nd quarter valued at about $74,241,000. Cooper Creek Partners Management LLC grew its stake in BKV by 24.7% in the 1st quarter. Cooper Creek Partners Management LLC now owns 2,103,230 shares of the company's stock worth $59,984,000 after acquiring an additional 416,281 shares in the last quarter. William Blair Investment Management LLC bought a new position in BKV in the 2nd quarter worth about $32,689,000. Value Aligned Research Advisors LLC increased its position in shares of BKV by 110.5% during the second quarter. Value Aligned Research Advisors LLC now owns 679,899 shares of the company's stock worth $18,602,000 after acquiring an additional 356,848 shares during the period. Finally, Bank of America Corp DE purchased a new position in shares of BKV during the second quarter worth approximately $16,177,000.

About BKV

BKV Corporation is a U.S. energy company focused on natural gas production and related businesses. It operates in the Barnett Shale in Texas and the Marcellus Shale in Pennsylvania, producing natural gas for sale to customers and markets across the region.

The company has expanded beyond production into natural gas gathering and processing, natural gas-fired power generation, and carbon capture and sequestration. These activities connect its gas operations with energy delivery and projects intended to reduce emissions.

Founded as part of Thailand-based Banpu's U.S.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.